DOCSLIB.ORG

Print ED376034.TIF

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Print ED376034.TIF DOCUMENT RESUME ED 376 034 SE 054 720 TITLE Grants for Science Education, 1994. INSTITUTION Howard Hughes Medical Inst., Chevy Chase, MD. Office of Grants and Special Programs. PUB DATE 94 NOTE 151p. AVAILABLE FROM Howard Hughes Medical Institute, Office of Grants and Special Programs, 4000 Jones Bridge Road, Chevy Chase, MD 20815-6789. PUB TYPE Guides Non-Classroom Use (055) EDRS PRICE MF01/PC07 Plus Postage. DESCRIPTORS *Biomedicine; *Grants; Higher Education; *Research; *Science Education; Secondary Education ABSTRACT To help strengthen education in medicine, biology, and related sciences, the Howard,Hughes Medical Institute (HHMI) launched a grants program in those areas on 1987. The grants support graduate, undergraduate, precollege and public science education, and fundamental biomedical research abroad. This document provides summaries of all projects receiving grants in 1993 and is also, in effect, a 1993 annual report for each programmatic area supported by HHMI. (ZWH) *********************************************************************** Reproductions supplied by EDRS are the best that can be made * from the original document. * *********************************************************************** a$ 8 , 1 i 111 I z t S I I A U R DEPARTMENT OF EDUCATION TO REPRODUCETHIS Once of EdocAi oda, Osearco Inc Imow.emedi ' PERMISSION GRANTED BY EOUCATIONAL RESONTER URCESINFORMATION MATERIAL HAS BEEN CE IERIC) ^, s document .as Deed reorocucec as eeReed oom toe owsed dr otogm.at, 6 - onginalmgI C Mdot changes nays oeed made to tooro,, .eooduc hod 0,4401' Points oI A* or opmods staled.. to.sdoco°P.m RESOURCES e'en, 00 °Ot nedossAnIY Ieptesedt TO THE EDUCATIONAL OERI DoSMod ot ("WY INFORMATION CENTER(ERIC) BEST COPY AVAILA Copyright ©1994 by the Howard Hughes Medical Institute Office of Grants and Special Programs. MI rights reserved. Howard Hughes Medical Institute Grants for Science Education 1994 Office of Grants and Special Programs 4 Howard Hughes Medical Institute Programs The Howard Hughes Medical the training of pre- and postdoctoral Institute was founded in 1953 by avi- scientists in the laboratories of ator-industrialist Howard R. Hughes. Hughes investigators: has provided Its charter, in part, reads: The pri-substantial support to the genome mary purpose and objective of tilemapping program which involves Howard Hughes Medical Institute international collection, dissemina- shall be the promotion of human tion, and coordination of data; pro- knowledge within the field of thevides research training to medical basic sciences (principally the field ofstudents through the Research medical research and medical educa- Scholars Program (conducted joint- tion) and the effective application ly with the National Institutes of thereof for the benefit of mankind. Health); and organizes scientific conferences, workshops, and pro- gram reviews. Biomedical Research Program 1111111111111111111111EMISIEME The Howard Hughes Medical Insti- Grants and Special tute is a nonprofit medical research Programs organization dedicated to basic bio- In the fall of 1987, as a complement medical research and education. Its to its research program, the Insti- principal objectives are the advance- tute launched a gran;: program to ment of fundamental knowledge in help strengthen education in the biomedical science and the applica- biological and related sciences. The tion of new scientific knowledge to program is administered through the alleviation of disease and the the Office of Grants and Special promotion of health. Through its program of direct conduct of med-Programs and has as its primary ical research in conjunction withobjectives the enhancement of sci- hospitals, the Institute employs over ence education at the graduate, 220 independent investigators whoundergmluate, and precollege lev- conduct research at Institute labora- els: the education of the public tories in more than 50 leading aca- about science; and the promotion of demic medical centers, hospitals, fundamental biomedical research and universities throughout theabroad. In addition, this office is United States. The number of inves- establishing a comprehensive tigators is expected to grow toassessment program. The grants about 270 within two years. extend across a wide range of insti- The Institute conducts research tutions involved in formal and infor- in five broad areas: cell biology and mal science education, including regulation genetics, immunology, colleges, universities, research cen- neuroscience, and structural biology. ters, medical schools, elementary In support of these research and secondary schools, and science efforts, the Institute is involved in museums. 5 A Since launching the grants pro-gram for graduate education in the gram, the Institute has developed biological sciences; undergraduate ar array of initiatives designed to institutions through an undergradu- help ensure the future quality and ate science education program: and vitality of the scientific enterprise. science museums through a precol- Today, the Institute supports gradu- lege and public science education ate students, medical students, and program. physicians through a grants pro- Contents Howard Hughes Medical Institute Programs Preface Introduction Graduate Science Education 2 Overview 4Predoctoral Fellowships in Biological Sciences 11Research Training Fellowships for Medical Students 1:3 Initial Year of Research 14 Continued Support 18Assessment 18Postdoctoral Research Fellowships for Physicians , 25Research Resources 25'Jackson Laboratory 26Cold Spring Harbor Laboratory 27 Marine Biological Laboratory 28Human Genome Organisation Undergraduate Science Education 29Undergraduate Program Directors Meetings 29 1993 Meeting 30 1992 Meeting 32Undergraduate Program Grants, Phase II, 1993 and 1994 Competitions :35 Assessment Criteria 36New Awards, 1993 :37 Undergraduate Research, Including Opportunities for Women and Minority Students Underrepresented in the Sciences 38Equipment and Laboratory Development :39 Precollege and Outreach Programs 40Overview of the Undergraduate Program, Phase I, 1988-1992 40Grants Competitions and Awards 40Undergraduate Research: Opportunities for Women and Minority Students Underrepresented in the Sciences 4:3 Faculty Development in the Sciences 44Curriculum and Laboratory Development and Equipment 44Precollege and Outreach Programs Precollege and Public Science Education 55Precollege Science Education Initiative for Museums 57Science Museum Program Directors Meeting 58Awards, 1993 59Children's and Youth Programs 00Teache Training and Curriculum Enhancement 61 Family and Community-Oriented Programs 61 Evaluation and Assessment 61Precollege Science Education Initiative for Biomedical Research Institutions, 1994 Competition 63 Woodrow Wilson National Fellowship Foundation, National Leadership Program for Teachers 64Precollege Science Education Initiative for MuseumsOverview, 1992 Awards 68Local Precollege Education Initiatives International Program 79Research Grants 80 Eligible Countries 80Application and Selection Process 81 Grant Awards 81 Grant Activities 82Other International Activities 82U.S. and Mexican National Academies 82 International Education Activities Program Assessment 89Overview 89Graduate Education in the Biological Sciences 89 Medical Student Fellows 90Predoctoral and Postdoctoral Fellows 90Undergraduate Science Education 90Precollege and Public Science Education 91 Local Precollege Initiatives 92Education and Career Outcomes of Physician-Scientists 93 Overview of the Medical Student Tracking Project 94The Annual Pool of Students in M.D./Ph.D. Programs 97Elapsed Years from Medical School Matriculation to M.D. Graduation 09 interest in Research Careers as Expressed at M.D. Graduation 100Years of Clinical Training Following Receipt of the M.D. Degree 102 Preliminary Data on Appointments to Faculty Positions in Medical Schools 103Doctoral Degrees Earned as of June 1992 107Sequence and Timing of the M.D. and Ph.D. Degrees vi Policies and Procedures for Grant Applications 109 The Institute Grant-Making Process 111Graduate Education in the Biological Sciences 111 Predoctoral Fellowships in Biological Sciences 111 Research Training Fellowships for Medical Students 111 Postdoctoral Research Fellowships for Physicians 112 Research Resources 112 Undergraduate Biological Sciences Education Program 113 1094 Undergraduate Program Competition 113Precollege and Public Science Education 114 ?recollege Science Education Initiative for Biomedical Research Institutions 114I ,ocal Initiatives 115International Program 115International Research Scholars Program 115Research Grants for Eastern Europe and the Former Soviet Union 115Other International Activities 115 Program Assessment 116 Unsolicited Proposals Bibliography Selected Grants Publications Howard Hughes Medical Institute 121Trustees 122Officers 123 Principal Staff Members 124 Office of Grants and Special Programs vii 1993 Awardees Graduate Science Education Predoctoral Fellowships in Biological Sciences, 1993 Fellows 19Research Training Fellowships for Medical Students, 1993 Fellows 24Postdoctoral Research Fellowships for Physicians, 1993 Awardees Undergraduate Science Education 8 Undergraduate Biological Sciences Education Program, 1093 Awards 49Undergraduate Biological Sciences Education Program, 1993 Grant Summaries Precollege and Public Science Education 73Precollege Science Education Initiative for Science Museums, 1991 Awards 74Precollege Science Education Initiative for Science Museums. 1993 Grant
Load more

Recommended publications
  • Mothers in Science
    The aim of this book is to illustrate, graphically, that it is perfectly possible to combine a successful and fulfilling career in research science with motherhood, and that there are no rules about how to do this. On each page you will find a timeline showing on one side, the career path of a research group leader in academic science, and on the other side, important events in her family life. Each contributor has also provided a brief text about their research and about how they have combined their career and family commitments. This project was funded by a Rosalind Franklin Award from the Royal Society 1 Foreword It is well known that women are under-represented in careers in These rules are part of a much wider mythology among scientists of science. In academia, considerable attention has been focused on the both genders at the PhD and post-doctoral stages in their careers. paucity of women at lecturer level, and the even more lamentable The myths bubble up from the combination of two aspects of the state of affairs at more senior levels. The academic career path has academic science environment. First, a quick look at the numbers a long apprenticeship. Typically there is an undergraduate degree, immediately shows that there are far fewer lectureship positions followed by a PhD, then some post-doctoral research contracts and than qualified candidates to fill them. Second, the mentors of early research fellowships, and then finally a more stable lectureship or career researchers are academic scientists who have successfully permanent research leader position, with promotion on up the made the transition to lectureships and beyond.
    [Show full text]
  • DRAFT EP200617 Tonix
    Developing Multiple Vaccines Against COVID-19 Based on Live Synthetic Horsepox Platform with Dr. Seth Lederman Tonix Pharmaceuticals An Empowered Patient Podcast Published June 30, 2020 Karen Jagoda: Welcome to the empoweredpatientpodcast.com show. I'm Karen Jagoda, and my guest today is Dr. Seth Lederman. He is the co-founder, CEO, and chairman of New York city based Tonix Pharmaceuticals. They're a research and development company, T-O-N-I-X, P-H-A-R-M-a .com. the topic today is COVID- 19 vaccine development. So, welcome to the show today, Seth. I appreciate you taking a few minutes. Dr. Seth Lederman: Thank you for having me on the show. Karen Jagoda: Let's just jump right in and talk a little bit about what your mission at Tonix is and what conditions you generally have been focusing on. Dr. Seth Lederman: Thanks. Tonix is really focused on trying to solve important problems facing society. We're a drug development company, and historically we've done a lot of work in the areas of psychiatry and pain, but I am an immunologist, and we've had a long interest in infectious disease. So, when COVID struck, we applied our tools to try to solve this problem also. Karen Jagoda: What's the common thread between your previous work and vaccines for the virus, the coronavirus? Dr. Seth Lederman: We've been working on a platform that's called a vaccine vector. A vaccine vector is like a pickup truck. We can put any kind of vaccine antigen into the payload of the truck.
    [Show full text]
  • Female Fellows of the Royal Society
    Female Fellows of the Royal Society Professor Jan Anderson FRS [1996] Professor Ruth Lynden-Bell FRS [2006] Professor Judith Armitage FRS [2013] Dr Mary Lyon FRS [1973] Professor Frances Ashcroft FMedSci FRS [1999] Professor Georgina Mace CBE FRS [2002] Professor Gillian Bates FMedSci FRS [2007] Professor Trudy Mackay FRS [2006] Professor Jean Beggs CBE FRS [1998] Professor Enid MacRobbie FRS [1991] Dame Jocelyn Bell Burnell DBE FRS [2003] Dr Philippa Marrack FMedSci FRS [1997] Dame Valerie Beral DBE FMedSci FRS [2006] Professor Dusa McDuff FRS [1994] Dr Mariann Bienz FMedSci FRS [2003] Professor Angela McLean FRS [2009] Professor Elizabeth Blackburn AC FRS [1992] Professor Anne Mills FMedSci FRS [2013] Professor Andrea Brand FMedSci FRS [2010] Professor Brenda Milner CC FRS [1979] Professor Eleanor Burbidge FRS [1964] Dr Anne O'Garra FMedSci FRS [2008] Professor Eleanor Campbell FRS [2010] Dame Bridget Ogilvie AC DBE FMedSci FRS [2003] Professor Doreen Cantrell FMedSci FRS [2011] Baroness Onora O'Neill * CBE FBA FMedSci FRS [2007] Professor Lorna Casselton CBE FRS [1999] Dame Linda Partridge DBE FMedSci FRS [1996] Professor Deborah Charlesworth FRS [2005] Dr Barbara Pearse FRS [1988] Professor Jennifer Clack FRS [2009] Professor Fiona Powrie FRS [2011] Professor Nicola Clayton FRS [2010] Professor Susan Rees FRS [2002] Professor Suzanne Cory AC FRS [1992] Professor Daniela Rhodes FRS [2007] Dame Kay Davies DBE FMedSci FRS [2003] Professor Elizabeth Robertson FRS [2003] Professor Caroline Dean OBE FRS [2004] Dame Carol Robinson DBE FMedSci
    [Show full text]
  • Discovery and Assessment of Conserved Pax6 Target Genes and Enhancers
    Edinburgh Research Explorer Discovery and assessment of conserved Pax6 target genes and enhancers Citation for published version: Coutinho, P, Pavlou, S, Bhatia, S, Chalmers, KJ, Kleinjan, DA & van Heyningen, V 2011, 'Discovery and assessment of conserved Pax6 target genes and enhancers', Genome Research, vol. 21, no. 8, pp. 1349- 59. https://doi.org/10.1101/gr.124115.111 Digital Object Identifier (DOI): 10.1101/gr.124115.111 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Genome Research Publisher Rights Statement: Copyright © 2011 by Cold Spring Harbor Laboratory Press. EuropePMC open access link General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 26. Sep. 2021 Method Discovery and assessment of conserved Pax6 target genes and enhancers Pedro Coutinho,1 Sofia Pavlou, Shipra Bhatia, Kevin J. Chalmers, Dirk A. Kleinjan, and Veronica van Heyningen Medical Research Council (MRC) Human Genetics Unit, Western General Hospital, Edinburgh EH4 2XU, United Kingdom The characterization of transcriptional networks (TNs) is essential for understanding complex biological phenomena such as development, disease, and evolution.
    [Show full text]
  • Regulationseinheiten in Evolution, Entwicklung Und Humaner Krankheit
    Regulatory units in evolution, development, and human disease Regulationseinheiten in Evolution, Entwicklung und humaner Krankheit Der Naturwissenschaftlichen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg zur Erlangung des Doktorgrades Dr.rer.nat. vorgelegt von Lifei Li Als Dissertation genehmigt von der Naturwissenschaftlichen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg Tag der mündlichen Prüfung: 28.05.2020 Vorsitzender des Promotionsorgans: Prof. Dr. Georg Kreimer Gutachter: Prof. Dr. Leila Taher Prof. Dr. Christian Pilarsky Declaration of Authorship I, Lifei Li, declare that this thesis, titled “Regulatory units in evolution, development, and human disease”, and the work presented in it are my own. I confirm that I did not submit previously any part of this thesis for any degree or any other qualification at Friedrich-Alexander University Erlangen-Nürnberg, nor at any other institution. I also declare that, where I have consulted the published work of others, this is always clearly attributed, and where I have quoted from the work of others, the source is always given. I also confirm that, where the thesis is based on work done by myself jointly with others, I have made clear exactly what was done by others and what I have contributed myself. i Abstract Misregulation of gene expression can result in broad types of diseases and abnormalities. For elucidating the molecular mechanisms underlying evolution, development and disease, the 2% protein-coding regions in the human genome have been studied for decades, but the the 98% non-coding regions remain less understood. Many studies have revealed that evolutionary con- served non-coding elements (CNEs) act as cis-regulatory elements (CREs).
    [Show full text]
  • Annual Report 2010 © Copyright 2011
    Centre for Genomic Regulation Annual Report 2010 © Copyright 2011 Produced by: Department of Communication & Public Relations Centre for Genomic Regulation (CRG) Dr. Aiguader, 88 08003 Barcelona, Spain www.crg.eu Texts and graphics: CRG Researchers, Department of Communication and Public Relations Graphic Design: Genoma ArtStudio SCP (www.genoma-artstudio.com) Photography: Ivan Martí Printing: Novoprint, S.A. Legal deposit: B-24966-2011 CONTENTS CRG Scientific Structure 6 CRG Core Facilities Structure 8 CRG Management Structure 10 CRG Scientific Advisory Board (SAB) 12 CRG Business Board 13 Year Retrospect by the Director of the CRG: Miguel Beato 14 Research Programmes Gene Regulation 16 > Chromatin and gene expression 18 > Regulation of alternative pre-mRNA splicing during cell differentiation, development and disease 22 > Regulation of protein synthesis in eukaryotes 26 > Translational control of gene expression 29 Differentiation and Cancer 34 > Hematopoietic differentiation and stem cell biology 36 > Reprogramming and regeneration 40 > Epigenetics events in cancer 43 > Epithelial homeostasis and cancer 48 > Mechanisms of cancer and aging 51 Genes and Disease 54 > Genetic causes of disease 56 > Gene therapy 65 > Gene Function and murine models of disease 69 > Neurobehavioral phenotyping of mouse models of disease 73 > Genomic and epigenomic variation in disease 77 Bioinformatics and Genomics 82 > Bioinformatics and genomics 84 > Comparative bioinformatics 92 > Comparative genomics 96 > Evolutionary genomics 101 > Gene function and evolution
    [Show full text]
  • EMBO Facts & Figures
    excellence in life sciences Reykjavik Helsinki Oslo Stockholm Tallinn EMBO facts & figures & EMBO facts Copenhagen Dublin Amsterdam Berlin Warsaw London Brussels Prague Luxembourg Paris Vienna Bratislava Budapest Bern Ljubljana Zagreb Rome Madrid Ankara Lisbon Athens Jerusalem EMBO facts & figures HIGHLIGHTS CONTACT EMBO & EMBC EMBO Long-Term Fellowships Five Advanced Fellows are selected (page ). Long-Term and Short-Term Fellowships are awarded. The Fellows’ EMBO Young Investigators Meeting is held in Heidelberg in June . EMBO Installation Grants New EMBO Members & EMBO elects new members (page ), selects Young EMBO Women in Science Young Investigators Investigators (page ) and eight Installation Grantees Gerlind Wallon EMBO Scientific Publications (page ). Programme Manager Bernd Pulverer S Maria Leptin Deputy Director Head A EMBO Science Policy Issues report on quotas in academia to assure gender balance. R EMBO Director + + A Conducts workshops on emerging biotechnologies and on H T cognitive genomics. Gives invited talks at US National Academy E IC of Sciences, International Summit on Human Genome Editing, I H 5 D MAN 201 O N Washington, DC.; World Congress on Research Integrity, Rio de A M Janeiro; International Scienti c Advisory Board for the Centre for Eilish Craddock IT 2 015 Mammalian Synthetic Biology, Edinburgh. Personal Assistant to EMBO Fellowships EMBO Scientific Publications EMBO Gold Medal Sarah Teichmann and Ido Amit receive the EMBO Gold the EMBO Director David del Álamo Thomas Lemberger Medal (page ). + Programme Manager Deputy Head EMBO Global Activities India and Singapore sign agreements to become EMBC Associate + + Member States. EMBO Courses & Workshops More than , participants from countries attend 6th scienti c events (page ); participants attend EMBO Laboratory Management Courses (page ); rst online course EMBO Courses & Workshops recorded in collaboration with iBiology.
    [Show full text]
  • David-Evans.Pdf
    Virus synthesis as a tool for assembling large virus vaccines David Evans, PhD Professor and Vice-Dean Research Dept. of Medical Microbiology & Immunology and Li Ka-Shing Institute of Virology University of Alberta Disclosures: DE is an author of relevant patents and is entitled to, or receives, financial compensation for his contributions to these intellectual properties. DE is also a paid consultant to Tonix Pharmaceuticals Ltd. These activities have been reported to the University of Alberta as required by COI and COC policies. Poxviruses The world’s first vaccines Yaba tumour virus Myxoma virus SFV Sheep pox Monkeypox Vaccinia Variola Cotia virus Swinepox Fowlpox A. moorei EPV C. biennis EPV Smallpox • Variola virus causes human smallpox • Not as infectious as people think, but mortality is 2-50% • An ancient disease with great historical impact • The earliest medical description is from China (~340 AD) where Ko Hung described “marauder’s pox” and a possible date of ~45 AD Smallpox and the origins of vaccination Variolation predates vaccination by centuries • Resemblance to camelpox virus suggests variola arose in Asia • By ~1550 Chinese texts described how variolation, with scab material, could immunize against smallpox • Variolation may have much earlier Taoist origins, known secretly for ~500 yrs • Knowledge passed to the middle east and Europe by the 1700s Needham Smallpox eradication • Variolation came to Britain by the early 1700s, but even the most skilled variolator killed 1- 2 in 1,000 • Jenner’s vaccination replaces variolation after the 1790’s • Vaccinia virus was ultimately used to Edward Jenner (1749-1823) eradicate smallpox Vaccinia virus (VACV) The prototypical poxvirus • Large (~200 kb) double- stranded DNA virus.
    [Show full text]
  • Genetics Society News
    JULY 2012 | ISSUE 67 GENETICS SOCIETY NEWS In this issue The Genetics Society News is edited • New Honorary Members by David Hosken and items for future • Punnett’s Square issues can be sent to the editor, by email to [email protected]. • Meetings The Newsletter is published twice a • Summer Student and Travel Reports year, with copy dates of 1st June and 26th November. Collecting saltwater samples in the Dead Sea, part of a fieldwork grant. See page 39 A WORD FROM THE EDITOR A word from the editor Welcome to issue 67. not fail (why not at trip to Lisbon instead?). It includes the amusing elcome to another issue of the dialog; WNewsletter. We include the usual interesting range of articles, ‘Columbus: “But your guidelines student reports, meeting reports and say that a lot of preliminary data so on, but I am also very pleased are not required for proposals of to include the biographies of our high impact”. newest Honorary Members, a group Ferdinand: “And you believe that? of outstanding geneticists who have Hahahaha! What an idiot”.’ all made great contributions to the The article makes some excellent field. I wonder what they would points and makes them well. It is make of an amusing, yet somewhat a must-read, and reviewers and depressing commentary published panels should remember that if in a recent issue of Genome Biology it cannot fail and if we know the (Goodbye Columbus: Genome answers beforehand, it is not Biology 2012 13:155)? really science. The article places Columbus before Read on and enjoy, and I can only the King and Queen of Spain after hope that the summer weather his funding application to sail west where you are, is a darn sight to seek the Indies has been rejected.
    [Show full text]
  • Year in Review
    Year in review For the year ended 31 March 2017 Trustees2 Executive Director YEAR IN REVIEW The Trustees of the Society are the members Dr Julie Maxton of its Council, who are elected by and from Registered address the Fellowship. Council is chaired by the 6 – 9 Carlton House Terrace President of the Society. During 2016/17, London SW1Y 5AG the members of Council were as follows: royalsociety.org President Sir Venki Ramakrishnan Registered Charity Number 207043 Treasurer Professor Anthony Cheetham The Royal Society’s Trustees’ report and Physical Secretary financial statements for the year ended Professor Alexander Halliday 31 March 2017 can be found at: Foreign Secretary royalsociety.org/about-us/funding- Professor Richard Catlow** finances/financial-statements Sir Martyn Poliakoff* Biological Secretary Sir John Skehel Members of Council Professor Gillian Bates** Professor Jean Beggs** Professor Andrea Brand* Sir Keith Burnett Professor Eleanor Campbell** Professor Michael Cates* Professor George Efstathiou Professor Brian Foster Professor Russell Foster** Professor Uta Frith Professor Joanna Haigh Dame Wendy Hall* Dr Hermann Hauser Professor Angela McLean* Dame Georgina Mace* Dame Bridget Ogilvie** Dame Carol Robinson** Dame Nancy Rothwell* Professor Stephen Sparks Professor Ian Stewart Dame Janet Thornton Professor Cheryll Tickle Sir Richard Treisman Professor Simon White * Retired 30 November 2016 ** Appointed 30 November 2016 Cover image Dancing with stars by Imre Potyó, Hungary, capturing the courtship dance of the Danube mayfly (Ephoron virgo). YEAR IN REVIEW 3 Contents President’s foreword .................................. 4 Executive Director’s report .............................. 5 Year in review ...................................... 6 Promoting science and its benefits ...................... 7 Recognising excellence in science ......................21 Supporting outstanding science .....................
    [Show full text]
  • UNITED STATES SECURITIES and EXCHANGE COMMISSION Washington, D.C
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): December 4, 2020 _____________________ TONIX PHARMACEUTICALS HOLDING CORP. (Exact name of registrant as specified in its charter) Nevada 001-36019 26-1434750 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 26 Main Street, Suite 101, Chatham, New Jersey 07928 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (212) 980-9155 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock TNXP The NASDAQ Global Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
    [Show full text]
  • Veronica Van Heyningen
    Speaker: Veronica van Heyningen <MRC Human Genetics Unit, Edinburgh, Scotland> Title: “PAX6 and SOX2 in disease, development and evolution” Date: Thursday, July 17 Time: 16:00 P.M.〜17:00 P.M. Place: 7th floor Conference Room, CDB Summary PAX6 was first associated with the human eye anomaly aniridia, where the iris is hypoplastic or absent, but there are a number of associated anomalies involving the retina lens and cornea as well. Additional abnormalities have been observed in the brain and olfactory system as well, in the heterozygous aniridia patients. SOX2 was recently shown to be mutated in a significant proportion of bilateral and severe anophthalmias. Small eye, the rodent model system for aniridia and PAX6, the rodent models for Pax6 mutations has revealed many key factors on the role for Pax6, since the homozygous null mutants which are neonatally lethal, can be studied in great detail from the mouse and rat models. In contrast, the heterozygous mouse model for SOX2 knockout has no discernible eye defect and the homozygote null mice are pre-implantation lethals. The human-mouse phenotypic difference is intriguing and requires further work. Following its key role in totipotent ES cells, SOX2 is a major early neural marker, as well as being expressed in mouse lens and retina during development. We have learnt a lot about PAX6 function from the spectrum of human eye disease-associated mutations, including some chromosomal rearrangements which revealed an extensive set of downstream control elements regulating the spatiotemporal expression pattern of the gene. The existence of this complex control system is further emphasized by studying the evolutionary sequence conservation of vertebrate Pax6 in the 200 kb genomic regions surrounding the gene.
    [Show full text]